Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$877M |
| 2 |
Booking.com
BKNG
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$329M |
| 4 |
Boeing
BA
|
+$303M |
| 5 |
Walmart Inc
WMT
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$544M |
| 2 |
iShares MBS ETF
MBB
|
+$461M |
| 3 |
NVIDIA
NVDA
|
+$452M |
| 4 |
T-Mobile US
TMUS
|
+$426M |
| 5 |
Apple
AAPL
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 3.01% |
| 3 | Financials | 2.28% |
| 4 | Consumer Discretionary | 2.27% |
| 5 | Industrials | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
CALL
Veeva Systems
VEEV
$41B
| $74.8M | 0.02% |
240,600
-2,800
| -1% | -$781K |
|
802
CALL
Chewy
CHWY
$9.15B
| $74.6M | 0.02% |
935,700
-406,900
| -30% | -$31.5M |
|
803
PUT
CRISPR Therapeutics
CRSP
$5.22B
| $74.5M | 0.02% |
459,900
+95,200
| +26% | +$11.6M |
|
804
PUT
Equinix
EQIX
$105B
| $74.3M | 0.02% |
92,600
+27,800
| +43% | +$20.6M |
|
805
CALL
Lennar Class A
LEN
$20.5B
| $74.3M | 0.02% |
772,064
+284,488
| +58% | +$27.5M |
|
806
Nike
NKE
$61.2B
| $74M | 0.02% |
478,952
+309,700
| +183% | +$41.7M |
|
|
MRTX
807
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $73.9M | 0.02% |
457,597
+46,382
| +11% | +$7.45M |
|
808
AstraZeneca
AZN
$244B
| $73.8M | 0.02% |
616,346
-573,472
| -48% | -$62.9M |
|
809
PUT
GDS Holdings
GDS
$6.97B
| $73.8M | 0.02% |
940,500
+500,700
| +114% | +$38.8M |
|
|
JOYY
810
PUT
JOYY Inc
JOYY
$3.74B
| $73.7M | 0.02% |
1,117,200
+48,600
| +5% | +$4.13M |
|
811
KeyCorp
KEY
$24.5B
| $73.7M | 0.02% |
3,566,709
+1,181,640
| +50% | +$25.7M |
|
812
CALL
Nucor
NUE
$61.7B
| $73.5M | 0.02% |
766,600
+90,200
| +13% | +$8.44M |
|
813
CALL
Tilray
TLRY
$640M
| $73.5M | 0.02% |
406,318
+109,968
| +37% | +$19.3M |
|
814
CALL
Workday
WDAY
$51B
| $73.3M | 0.02% |
307,200
+37,000
| +14% | +$8.9M |
|
815
Sea Limited
SE
$75.5B
| $73.3M | 0.02% |
266,916
+202,265
| +313% | +$51.3M |
|
816
LendingTree
TREE
$444M
| $73.3M | 0.02% |
345,844
+105,759
| +44% | +$22.2M |
|
817
CVS Health
CVS
$121B
| $73M | 0.02% |
874,974
-320,708
| -27% | -$26.3M |
|
818
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.3B
| $73M | 0.02% |
211,640
+106,708
| +102% | +$36.4M |
|
819
Lear
LEA
$8.16B
| $73M | 0.02% |
+416,385
| New | +$77M |
|
|
BNY
820
Bank of New York Mellon
BNY
$111B
| $72.9M | 0.02% |
1,423,936
+565,451
| +66% | +$28.3M |
|
821
PUT
NextEra Energy
NEE
$179B
| $72.9M | 0.02% |
994,200
-39,600
| -4% | -$2.97M |
|
822
Nordson
NDSN
$17.3B
| $72.8M | 0.02% |
331,534
+247,443
| +294% | +$52.5M |
|
823
CALL
Akamai
AKAM
$18B
| $72.6M | 0.02% |
622,600
+50,300
| +9% | +$5.61M |
|
|
FTCH
824
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $72.6M | 0.02% |
1,441,039
-673,087
| -32% | -$31.9M |
|
|
SNV
825
DELISTED
Synovus
SNV
| $72.4M | 0.02% |
1,650,395
+137,098
| +9% | +$6.44M |
|
Similar funds
Ken Griffin's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.7% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
- Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
- Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
- Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
- Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
- Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
- Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.